Skip to content
Home/Companies/MedTech/Blueprint Genetics

Blueprint Genetics

MedTech·Finland·Exited 2020·Held 3yr
Entry
2017
Hold
3yr
Exit
2020

Who owns Blueprint Genetics?

Blueprint Genetics is a Finnish MedTech company, now owned by Quest Diagnostics, which acquired it in 2020 from Creathor Ventures.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Creathor Ventures
Investor
Creathor Ventures
Creathor Venture Fund III · 2012 · VC

Key facts

HQFinland
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
Quest Diagnostics
Exit Year
2020

More from Creathor Venture Fund III

Other portfolio companies in the same fund.

Allthings Technologies
Allthings Technologies
Active
SaaSSwitzerland· 2017
EchoRing (R3 Communications)
EchoRing (R3 Communications)
Active
Deep TechGermany· 2017
Humanoo
Exited 2024
HealthTechGermany· 2017
to TELUS Health
CryoTherapeutics
CryoTherapeutics
Active
MedTechBelgium· 2016
COBI
Exited 2017
MobilityGermany· 2015
to Bosch eBike Systems
Digital Insurance Group (Knip)
Active
FintechSwitzerland· 2015

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Blueprint Genetics?

Blueprint Genetics is now owned by Quest Diagnostics, which acquired it in 2020 from Creathor Ventures.

When did Quest Diagnostics acquire Blueprint Genetics?

Quest Diagnostics acquired Blueprint Genetics in 2020, buying from Creathor Ventures.

Who did Blueprint Genetics sell to?

Creathor Ventures sold Blueprint Genetics to Quest Diagnostics in 2020 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue